386 related articles for article (PubMed ID: 23121338)
1. Comparison of hybrid and sequential therapies for Helicobacter pylori eradication in Iran: a prospective randomized trial.
Sardarian H; Fakheri H; Hosseini V; Taghvaei T; Maleki I; Mokhtare M
Helicobacter; 2013 Apr; 18(2):129-34. PubMed ID: 23121338
[TBL] [Abstract][Full Text] [Related]
2. Comparison Between 10- and 14-Day Hybrid Regimens for Helicobacter pylori Eradication: A Randomized Clinical Trial.
Metanat HA; Valizadeh SM; Fakheri H; Maleki I; Taghvaei T; Hosseini V; Bari Z
Helicobacter; 2015 Aug; 20(4):299-304. PubMed ID: 25752357
[TBL] [Abstract][Full Text] [Related]
3. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
[TBL] [Abstract][Full Text] [Related]
4. Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea.
Kim N; Park SH; Seo GS; Lee SW; Kim JW; Lee KJ; Shin WC; Kim TN; Park MI; Park JJ; Hong SJ; Shim KN; Kim SW; Shin YW; Chang YW; Chun HJ; Lee OJ; Jeon WJ; Park CG; Cho CM; Park CH; Won SY; Lee GH; Park KS; Shin JE; Kim HU; Park JY; Chae HS; Song GA; Kim JG; Yoon BC; Seol S; Jung HC; Chung IS
Helicobacter; 2008 Dec; 13(6):542-9. PubMed ID: 19166420
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study.
Lim JH; Lee DH; Choi C; Lee ST; Kim N; Jeong SH; Kim JW; Hwang JH; Park YS; Lee SH; Shin CM; Jo HJ; Jang ES; Song Is; Jung HC
Helicobacter; 2013 Jun; 18(3):180-6. PubMed ID: 23305083
[TBL] [Abstract][Full Text] [Related]
6. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients.
Park HG; Jung MK; Jung JT; Kwon JG; Kim EY; Seo HE; Lee JH; Yang CH; Kim ES; Cho KB; Park KS; Lee SH; Kim KO; Jeon SW
Aliment Pharmacol Ther; 2012 Jan; 35(1):56-65. PubMed ID: 22066530
[TBL] [Abstract][Full Text] [Related]
7. Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial.
Chung JW; Jung YK; Kim YJ; Kwon KA; Kim JH; Lee JJ; Lee SM; Hahm KB; Lee SM; Jeong JY; Yun SC
J Gastroenterol Hepatol; 2012 Nov; 27(11):1675-80. PubMed ID: 22849546
[TBL] [Abstract][Full Text] [Related]
8. Ten and eight-day sequential therapy in comparison to standard triple therapy for eradicating Helicobacter pylori infection: a randomized controlled study on efficacy and tolerability.
Paoluzi OA; Visconti E; Andrei F; Tosti C; Lionetti R; Grasso E; Ranaldi R; Stroppa I; Pallone F
J Clin Gastroenterol; 2010 Apr; 44(4):261-6. PubMed ID: 20195162
[TBL] [Abstract][Full Text] [Related]
9. A comparison between sequential therapy and a modified bismuth-based quadruple therapy for Helicobacter pylori eradication in Iran: a randomized clinical trial.
Fakheri H; Taghvaei T; Hosseini V; Bari Z
Helicobacter; 2012 Feb; 17(1):43-8. PubMed ID: 22221615
[TBL] [Abstract][Full Text] [Related]
10. Concomitant, sequential, and hybrid therapy for H. pylori eradication: a pilot study.
Zullo A; Scaccianoce G; De Francesco V; Ruggiero V; D'Ambrosio P; Castorani L; Bonfrate L; Vannella L; Hassan C; Portincasa P
Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):647-50. PubMed ID: 23747131
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
[TBL] [Abstract][Full Text] [Related]
12. One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin.
Cammarota G; Cannizzaro O; Tursi A; Papa A; Gasbarrini A; Cuoco L; Cianei R; Armuzzi A; Fedeli P; Fedeli G; Gasbarrini G
Aliment Pharmacol Ther; 1998 Jun; 12(6):539-43. PubMed ID: 9678813
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non-ulcer dyspepsia.
De Francesco V; Della Valle N; Stoppino V; Amoruso A; Muscatiello N; Panella C; Ierardi E
Aliment Pharmacol Ther; 2004 May; 19(9):993-8. PubMed ID: 15113366
[TBL] [Abstract][Full Text] [Related]
16. High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study.
Zullo A; Gatta L; De Francesco V; Hassan C; Ricci C; Bernabucci V; Cavina M; Ierardi E; Morini S; Vaira D
Aliment Pharmacol Ther; 2005 Jun; 21(12):1419-24. PubMed ID: 15948808
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of ranitidine bismuth citrate plus amoxycillin and clarithromycin as first- or second-line therapy to cure Helicobacter pylori infection.
Tursi A; Brandimarte G; Giorgetti G; Modeo ME; Gigliobianco A
Hepatogastroenterology; 2002; 49(46):1006-9. PubMed ID: 12143188
[TBL] [Abstract][Full Text] [Related]
18. A pilot study evaluating sequential administration of a PPI-amoxicillin followed by a PPI-metronidazole-tetracycline in Turkey.
Sezgin O; Altintaş E; Nayir E; Uçbilek E
Helicobacter; 2007 Dec; 12(6):629-32. PubMed ID: 18001405
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of standard-dose versus half-dose rabeprazole, clarithromycin, and amoxicillin in the treatment of Helicobacter pylori infection.
Mansour NM; Hashash JG; El-Halabi M; Ghaith O; Maasri K; Sukkarieh I; Malli A; Sharara AI
Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):865-70. PubMed ID: 21811161
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the efficacy and tolerability of four different therapeutic regimens for the Helicobacter pylori eradication.
Tursi A; Cammarota G; Montalto M; Papa A; Cuoco L; Veneto GM; Cannizzaro O; Fedeli G; Gasbarrini G
Panminerva Med; 1996 Sep; 38(3):145-9. PubMed ID: 9009677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
